Clinical efficacy of a xenogeneic collagen matrix in augmenting keratinized mucosa around implants: a randomized controlled prospective clinical trial.

AIM: The aim of this controlled randomized clinical trial was to evaluate the efficacy of a xenogeneic collagen matrix (CM) to augment the keratinized tissue around implants supporting prosthetic restorations at 6 months when compared with the standard treatment, the connective tissue autograft, CTG). MATERIALS AND METHODS: This randomized longitudinal parallel controlled clinical trial studied 24 patients with at least one location with minimal keratinized tissue (≤1 mm). MAIN OUTCOME MEASURE: The 6-month width of keratinized tissue. As secondary outcomes the esthetic outlook, the maintenance of peri-implant mucosal health and the patient morbidity were assessed pre-operatively and 1, 3, and 6 months post-operatively. RESULTS: At 6 months, Group CTG attained a mean width of keratinized tissue of 2.75 (1.5) mm, while the corresponding figure in Group CM was 2.8 (0.4) mm, the inter-group differences not being statistically significant. The surgical procedure in both groups did not alter significantly the mucosal health in the affected abutments. There was a similar esthetic result and significant increase in the vestibular depth in both groups as a result of the surgery. In the CM group it changed from 2.2 (3.3) to 5.1 (2.5) mm at 6 months. The patients treated with the CM referred less pain, needed less pain medication, and the surgical time was shorter, although these differences were not statistically significant when compared with the CTG group. CONCLUSIONS: These results prove that this new CM was as effective and predictable as the CTG for attaining a band of keratinized tissue.

Comparison between two different techniques for peri-implant soft tissue augmentation: Porcine dermal matrix graft versus tenting screw.

BACKGROUND: The thickness of the soft tissues around dental implants is crucial for both the preservation of the marginal bone and esthetic profile. Many authors have showed the thickened soft tissues favor a better peri-implant bone stability; however, different thickening techniques can be used for this aim. METHODS: Forty-seven patients were enrolled in this study, each one had one implant included in this analysis. According to the thickening procedure, patients were assigned into group A (porcine dermal matrix, n = 24) or B (healing abutment used as tenting screw to sustain the soft tissues, n = 23), soft tissue thickness was measured after flap elevation in a standardized way. Six months after implant placement, implants were uncovered and soft tissue thickness measured again. RESULTS: At second stage, 6 months after implant placement, the mean vertical thickness was 3.01 ± 0.58 mm in group A and 2.25 ± 0.53 mm in group B. The difference between the two groups at 6 months was significant (P < 0.001). The mean vertical gain in group A was 1.33 ± 0.71 mm, whereas it was 0.43 ± 0.55 mm in group B. This difference was also statistically significant (P < 0.001). CONCLUSION: The use of a healing abutment for "tenting effect" has limited efficacy to obtain a significant increase in soft tissue thickness. The use of a porcine dermal matrix at time of implant placement is effective to thicken peri-implant tissues.

Improvement of Periodontal Parameters with the Sole Use of Free Gingival Grafts in Orthodontic Patients: Correlation with Periodontal Indices. A 15-Month Clinical Study.

The aim of this study was to evaluate the changes in periodontal parameters solely using free gingival grafts during orthodontic treatment without any oral hygiene re-enforcement. METHODS: A total of 19 patients underwent periodontal examination before orthodontic treatment. Patients received oral hygiene instruction and professional hygiene therapy. Where needed; full periodontal treatment was completed. Only periodontally stable patients were included in the study. Periodontal indices and keratinized tissue were recorded at time 0 (T0) (delivery of orthodontic appliances), and at three months (T1) during orthodontic therapy; when surgery was performed. At T1; orthodontically treated sites with minimum keratinized tissue (≤1 mm) received a free gingival graft to enhance the band of keratinized tissue. At three months after surgery (T2), new measurements were recorded. The orthodontics-treated sites after three months (T1) were used as control. The same sites were used as a test three months after mucogingival correction (T2). Between T1 and T2; orthodontics was suspended; no professional oral hygiene was performed; and no additional oral hygiene instructions were given to the patient. No oral hygiene procedures were administered for 15 months (T3), when the final recordings were taken. RESULTS: The results showed that there was a worsening of gingival index (GI) and plaque index (PI) of the treated sites between T0 and T1 during initial orthodontics treatment; whereas there was an improvement of the gingival inflammation at T2 when compared with T1. At T2; there was also a statistically significant improvement in GI and PI compared with T0. A T3 improvement in periodontal parameters was sustained. A non-parametric test (Wilcoxon signed-rank test) was used for statistical analysis. CONCLUSIONS: Augmentation of the width of keratinized gingiva; as the sole treatment; favors the improvement of GI and PI during orthodontic therapy.

Clinical evaluation of a new collagen matrix (Mucograft prototype) to enhance the width of keratinized tissue in patients with fixed prosthetic restorations: a randomized prospective clinical trial.

AIM: The aim of this study was to test a new collagen matrix (CM) aimed to increase keratinized gingiva/mucosa when compared with the free connective tissue graft (CTG). MATERIAL AND METHODS: This randomized longitudinal parallel controlled clinical trial studied 20 patients with at least one location with minimal keratinized tissue (

Long-term clinical results on the use of bone-replacement grafts in the treatment of intrabony periodontal defects. Comparison of the use of autogenous bone graft plus calcium sulfate to autogenous bone graft covered with a bioabsorbable membrane.

BACKGROUND: Many clinical investigations have demonstrated the benefits of different regenerative approaches in the treatment of infrabony defects. The aim of this investigation was to evaluate the results obtained with the combination of autogenous bone grafting plus calcium sulfate and to compare this outcome with the results obtained using autogenous bone grafting with a bioabsorbable membrane. METHODS: Twelve subjects participated in this split-mouth trial. Twelve 2- or 3-wall periodontal defects were treated with a combination of autogenous bone grafting plus calcium sulfate (test) and were compared to 12 defects treated with autogenous bone grafting with a bioabsorbable membrane (control). Before surgery, subjects were instructed in oral hygiene techniques, and scaling and root planing were completed. Surgery was identical for both groups except for the regenerative material. After healing, subjects followed a periodontal maintenance program. Probing depth (PD), clinical attachment level, and bleeding on probing were recorded at baseline, 6 months, and 6 years. RESULTS: There were no statistical differences between test and control defects at baseline. At 6 months, there was a PD reduction of 4.3 +/- 1.0 mm in the control group and 4.4 +/- 1.1 mm in the test group. There was a clinical attachment gain of 3.5 +/- 1.1 mm in the control group and 3.6 +/- 1.0 mm in the test group. At 6 years, there was a PD reduction of 3.3 +/- 1.0 mm in the control group and 4.2 +/- 1.2 mm in the test group. There was a clinical attachment gain of 2.6 +/- 1.2 mm in the control group and 2.4 +/- 1.1 mm in the test group. Differences between treatment groups were not statistically significant at 6 months or 6 years. CONCLUSION: Both therapies led to significant short- and long-term improvements in the outcome variables assessed.

Esthetic and dimensional evaluation of free connective tissue grafts in prosthetically treated patients: a 1-year clinical study.

BACKGROUND: The aim of this study was to evaluate the predictability of the free connective tissue graft in prosthetically treated patients needing gingival augmentation. The following outcome variables were studied 1) dimensional changes of free connective gingival grafts; 2) color blending with adjacent tissues; and 3) periodontal and marginal health status, when compared to a non-surgical control group. METHODS: Two groups of patients without periodontitis were investigated. The test group (group A) consisted of 16 patients. The inclusion criteria for surgical correction were: 1) at least 1 site lacking (<1 mm) keratinized tissue and/or lacking vestibular depth; 2) insufficient plaque control; and 3) the selected site was scheduled to undergo or had already received a fixed prosthetic restoration. The control group (group B) included 14 patients with the same inclusion criteria, but declining to undergo surgery. Group A patients were treated with a free connective tissue graft to augment the keratinized tissue at the selected sites. The size of the graft was recorded at baseline (surgical intervention) and the width of keratinized tissue was measured at 1, 4, 26, and 52 weeks. Gingival inflammation and plaque accumulation were assessed at baseline and 52 weeks in both groups. Probing depth and clinical attachment levels were recorded at baseline and 26 and 52 weeks in both groups. Evaluation of the esthetic results was carried out at the end of the study. All patients in both groups received oral hygiene instructions and supragingival plaque and calculus removal before and at the end of the investigation. RESULTS: In group A, the results showed a mean amount of keratinized tissue of 5.81 +/- 1.42 mm at 26 weeks and 5.25 +/- 1.34 mm at 52 weeks. Mean shrinkage of the graft was 10.2% (P = 0.001) at 1 week, 28.4% (P = 0.0004) at 4 weeks, 37.2% (P = 0.0004) at 26 weeks, and 43.25% (P = 0.0004) at 52 weeks. All the dimensional changes were statistically significant, when compared to baseline. Evaluation of color blending with the surrounding gingiva demonstrated an "excellent result" at 52 weeks with an 87.5% agreement among the three masked examiners. In the test group, the periodontal indices improved or remained stable; in the control group, there was a minor improvement of the indices, with three patients showing a worse gingival inflammation score and two a worse plaque score. CONCLUSION: Although these results are not conclusive, mostly due to a lack of a large enough sample population, the statistically significant results shown in this investigation tend to support the use of gingival augmentation procedures in prosthetic patients with insufficient keratinized gingiva and/or shallow or absent vestibules, when they cannot demonstrate adequate plaque control.

Pé cavo: revisão da literatura / Cavus foot: review

OBJETIVO: Realizar uma revisão sobre o pé cavo, sua fisiopatologia, avaliação clínica, diagnósticos diferenciais com ênfase na doença de Charcot-Marie-Tooth e tratamento. MÉTODO: Revisão não sistemática de artigos abordando a fisiopatologia do pé cavo, avaliação clínica, diagnósticos diferenciais e tratamento. RESULTADOS E DISCUSSÃO: Foram utilizados 33 artigos de língua inglesa e 02 artigos em português para a confecção desta revisão. CONCLUSÃO: O pé cavo é geralmente secundário a doenças neurológicas, em especial a doença de Charcot-Marie-Tooth e raramente é originado por doenças não neurológicas. O diagnóstico etiológico do pé cavo permite um melhor tratamento, cirúrgico ou não, com adequada orientação ao paciente quanto ao prognóstico e eficácia da terapia.

OBJECTIVE: We realize a review about cavus foot, discussing pathophysiology, clinical evaluation, differential diagnosis with emphasis on Charcot-Marie-Tooth Disease and treatment. METHOD: We perform a non-systematic review of articles about cavus foot pathophysiology, physical examination, etiology and treatment. RESULTS AND DISCUSSION: We used 33 articles in english and 02 articles in portuguese for this review. CONCLUSION: The cavus foot is mostly a consequence of neurological etiologies, in particular Charcot-Marie-Tooth disease and rarely is caused by non-neurological diseases. The correct diagnosis allows better treatment, conservative or surgical, with appropriate guidance to patients in terms of prognosis and therapy effectiveness.

Immediate effects of using ankle-foot orthoses in the kinematics of gait and in the balance reactions in Charcot-Marie-Tooth disease / Efectos inmediatos del uso de una ortesis para tobillo-pie en la cinemática de la marcha y en las reacciones de equilibrio en la enfermedad de Charcot-Marie-Toot / Efeitos imediatos do uso de órteses tornozelo-pé na cinemática da marcha e nas reações de equilíbrio na doença de Charcot-Marie-Tooth

The Charcot-Marie-Tooth (CMT) disease is a peripheral hereditary neuropathy with progressive distal muscle atrophy and weakness, mainly in lower limbs, that evolves limiting the gait and balance. The objective of the study was to analyse the immediate effects of using Ankle-Foot Orthosis (AFO) in the gait's kinematics and balance in patients with CMT. Nine individuals were evaluated by Tinetti scales and Dynamic Gait Index (DGI) and gait's kinematics parameters through the motion capturing system. These evaluations were done before and during the use of AFO. Two-Way repeated analysis of variance was done to try the main or interaction effects related to "orthoses" and "repetition". A significant interaction effect was observed between the gait cycle and use the AFO to the average velocity (Wilks' Lambda=0.156, p=0.030, η2=0.844) like significant main effects in the ankle joint to the gait cycle (Wilks' Lambda=0.091, p=0.008, η2=0.909) and the use of AFO (Wilks' Lambda=0.444, p=0.013, η2=0.556). It was observed a significant change in the DGI scale during the use of AFO (p<0.05). The use of AFO promoted immediate effects on gait kinematics and in balance reactions. The results suggest that the use of AFO is an efficient strategy to stabilize the ankle joint, besides avoiding foot drop in patients with CMT.

La enfermedad de Charcot-Marie-Tooth (CMT) es una neuropatía periférica hereditaria caracterizada por atrofia y paresia progresiva de la musculatura distal, principalmente en los miembros inferiores, que evoluciona con limitaciones en la marcha y en el balance. El objetivo de esto estudio fue analizar los efectos inmediatos del uso de ortesis para tobillo-pie (OTP) en la cinemática de la marcha y en el balance de pacientes con CMT. Nueve sujetos fueron evaluados por las escalas de Tinetti y DynamicGait Index (DGI) y los parámetros cinemáticos de la marcha por la cinemetria. Las evaluaciones fueron realizadas antes y durante el uso de la ortesis. El análisis de variancia con medidas repetidas fue realizado para testar el principal efecto y de interacción de los factores "ortesis" y "repetición". Se observó un efecto de interacción significativo entre el ciclo de la marcha y el uso de OTP para la media de velocidad (Wilks' Lambda=0,156, p=0,030, η2=0,844), como también el principal efecto significativo en la articulación del tobillo para el ciclo de la marcha (Wilks' Lambda=0,091, p=0,008, η2=0,909) y para el uso de una OTP (Wilks' Lambda=0,444, p=0,013, η2=0,556). Se observó una modificación significativa en la escala DGI durante el uso de una OTP (p<0,05). El uso de una OTP promovió efectos inmediatos en la cinemática de la marcha y en las reacciones de balance. Los resultados obtenidos sugieren que el uso de OTP es una eficaz estrategia para estabilizar el tobillo, y evita la curvatura del pie en pacientes con la CMT.

A doença de Charcot-Marie-Tooth (CMT) é uma neuropatia periférica hereditária caracterizada por atrofia e paresia progressiva da musculatura distal, principalmente em membros inferiores, que evolui com limitações na marcha e no equilíbrio. O objetivo do estudo foi analisar os efeitos imediatos do uso de ÓrteseTornozelo-Pé (OTP) na cinemática da marcha e no equilíbrio de pacientes com CMT. Nove indivíduos foram avaliados pelas escalas de Tinetti e DynamicGait Index (DGI) e os parâmetros cinemáticos da marcha através de cinemetria. As avaliações foram realizadas antes e durante o uso das órteses. A análise de variância com medidas repetidas foi realizada para testar o efeito principal e de interação dos fatores "órtese" e "repetição". Foi observado um efeito de interação significativo entre o ciclo da marcha e o uso da OTP para a média da velocidade (Wilks' Lambda=0,156, p=0,030, η2=0,844), assim como efeito principal significante na articulação do tornozelo para o ciclo da marcha (Wilks' Lambda=0,091, p=0,008, η2=0,909) e para o uso da OTP (Wilks' Lambda=0,444, p=0,013, η2=0,556). Foi observada uma modificação significativa na escala DGI durante o uso da OTP (p<0,05). O uso de OTP promoveu efeitos imediatos na cinemática da marcha e nas reações de equilíbrio. Os resultados obtidos sugerem que o uso de OTP é uma estratégia eficaz na estabilização do tornozelo, além de evitar o derreamento do pé em pacientes com CMT.

Limitações do uso de órteses tornozelo-pé na doença de Charcot-Marie-Tooth: estudo de caso / Limitations of ankle-foot-orthosis use in Charcot-Marie-Tooth disease: a case study

A paresia distal crural, muito marcante nos pacientes com doença de Charcot-Marie-Tooth (CMT), provoca inúmeras alterações nos padrõesda marcha. Vários recursos de reabilitação têm sido propostos para gerenciar os problemas de deambulação, entre eles a utilização de órteses tornozelo-pé (OTP). O objetivo deste trabalho foi analisar efeitos imediatos do uso de OTP na cinemática da marcha e nos parâmetros estabilométricos em paciente com CMT. Buscou-se avaliar: o equilíbrio e a marcha, por meio da Escala de Avaliação da Mobilidade Orientada pelo Desempenho (POMA); a cinemática da marcha, com o sistema Qualisys Track Manager (QTM); e a estabilometria, utilizando a plataforma de força. As avaliações foram realizadas antes e durante o uso de OTP. Observou-se declínio na escala POMA durante o uso da OTP de 11%. Na cinemática da marcha, verificou-se decréscimo na velocidade e comprimento da passada, assim comoaumento na duração dela. Na estabilometria, observou-se aumento na velocidade médio-lateral e na velocidade média na condição sem restrição visual, e aumento em todos os parâmetros de velocidade e deslocamento na condição com restrição visual durante o uso da OTP. O paciente avaliado não apresentou melhoras imediatas com aplicação de OTP, fato justificado pela presença de contraturas e tempo de evolução da doença. A prescrição de órteses na CMT deve respeitar as particularidades do paciente e a forma de apresentação da patologia.

The distal crural weakness, very striking in patients with Charcot-Marie-Tooth disease (CMT), causes gait impairment. Several rehabilitationapproaches have been proposed to manage the ambulation problems, among them, the use of ankle-foot orthosis (AFO). The objective of this study is to analyze the immediate effects of using AFO in the gait kinematic and stabilometric parameters in a patient with CMT. We evaluated the balance and the gait using Performance Oriented Mobility Assessment (POMA) Scale, gait kinematics using the Qualisys Track Manager (QTM) system and stabilometry, using a force platform. The evaluations were performed before and during the use of AFO. A decreasing of POMA scores was observed when the patient used AFO (11%). In the gait kinematic a decrease was verified in the speed gait and step length, as an increase in the time. In the stabilometry was observed an increase in the mediolateral velocity and average velocity in the condition without visual restrictionand an increase in all parameters of velocity and displacement in thecondition with visual restriction during the use of the AFO. The assessedpatient didn?t present immediate improvement with the AFO due to contractures presented and the time of the disease course. Prescription of orthosis in the CMT should respect the patient?s particularities and the clinical manifestations, and the way the pathology is presented.

Efeitos do uso de órteses na doença de Charcot-Marie-Tooth: atualização da literatura / Orthoses effects in Charcot-Marie-Tooth disease: update

A Doença de Charcot-Marie-Tooth (DCMT) é a neuropatia periférica hereditária mais comum em seres humanos, apresentando incidência de 1:2.500 pessoas. A fraqueza distal crural na DCMT provoca inúmeras alterações na marcha, como, por exemplo, na velocidade, no comprimento, na largura e cadência dos passos. Vários recursos em reabilitação têm sido propostos para gerenciar os problemas de deambulação, dentre eles, destaca-se a utilização de órteses. O objetivo deste estudo é apresentar e discutir os resultados de estudos sobre os efeitos da utilização de órteses nos padrões de marcha na DCMT. Neste estudo foi utilizada atualização da literatura através das principais bases de dados nacionais/internacionais (SciELO, LILACS e MEDLINE), publicados entre os anos de 2006–2012. O tratamento da DCMT consiste em fisioterapia e utilização de equipamentos de assistência, visto que ainda não há fármacos ou terapia gênica capaz de atenuar os danos clínicos e funcionais. Tal associação busca maximizar a função e melhorar a qualidade de vida desses pacientes, na tentativa de evitar agravos adicionais relativos à incapacidade física. A partir de atualização de literatura é possível concluir que existe consenso sobre a utilização de órteses nos membros inferiores para promover a estabilização das articulações do tornozelo e um padrão de deambulação mais funcional, evitando sinergias inadequadas de movimento e atenuando o risco de quedas.

Charcot-Marie-Tooth (CMT) disease is the most common hereditary peripheral neuropathy in humans, presenting incidence of 1:2.500 people. The distal crural weakness of the CMT causes numerous gait impairment changes, for example, velocity, length, width and cadence of the steps. Several rehabilitation resources have been proposed to manage the walking problems, among them, the use of orthoses is highlighted. The objective of this study was to present and discuss the results of studies on the effects of orthotic uses in CMT gait patterns. In this study it was used to literature update through major national/international databases (SciELO, LILACS and MEDLINE), published between the years 2006–2012. The CMT treatment consisted of physical therapy and using of assistive equipment, since there are no drugs or gene therapy able to attenuate the clinical and functional damages. This association seeks to maximize the function and improve life quality of these patients in an attempt to prevent additional injuries related to physical disability. From literature update it is possible to conclude that there is a consensus on the use of lower limb orthoses to promote the stabilization of the ankle articulation and a more functional pattern of walking, avoiding inadequate synergy of movement and reducing the risk of falls.